US Patent 7258853 Antagonists of interleukin-15
Patent 7258853 was granted and assigned to Beth Israel Deaconess Medical Center on August, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+148 characters)
Article
Patent abstract
Disclosed herein are mutant IL-15 polypeptides and methods for using these polypeptides to modulate the immune response in a patient.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07258853 Antagonists of interleukin-15 US Patent 7258853 Antagonists of interleukin-15
Infobox
Patent Number
0725885300
Patent Number
725885300
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072588530
Date of Patent
August 21, 2007
0Patent Application Number
102452430
Date Filed
September 17, 2002
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072588530
Date of Patent
August 21, 2007
0Patent Application Number
102452430
Date Filed
September 17, 2002
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07258853 Antagonists of interleukin-15
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07258853
Date of patent
August 21, 2007
Patent application number
10245243
Date Filed
September 17, 2002
Patent primary examiner
Find more entities like US Patent 7258853 Antagonists of interleukin-15
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.